Taiho ( Taiho)

×

Status message

SESSION['ACCESSGRANTED'] value is

Primary tabs

Taiho's picture

Management

Contact Address

About Taiho

Taiho Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, Japan. Taiho is an R&D-driven specialty pharma focusing on the three fields of oncology, allergies and immunology, and urology. Taiho is the Japanese second-largest by prescription oral oncology sales.

Taiho press release, blog etc

Wed, 11/24/2021 - 13:45 Taiho Pharmaceutical Launches BUP-4 LADY, Japan's First OTC Medication Indicated for Urinary Urgency
Tue, 09/14/2021 - 14:03 Taiho Pharmaceutical Submits New Drug Application for its HSP90 Inhibitor Pimitespib (TAS-116) for GIST
Thu, 07/01/2021 - 12:53 Taiho Pharmaceutical to Provide Matching Funds to Select Crowdfunded Projects Addressing Issues in the Field of Oncology with New Taiho Smile Support Program
Fri, 10/26/2018 - 16:46 FDA Accepts Supplemental New Drug Application for LONSURF
Thu, 09/13/2018 - 14:24 Taiho Pharmaceutical to Launch Zenol Diclodirect
Tue, 09/11/2018 - 14:32 Taiho Pharmaceutical to Support the Pink Ribbon Campaign Again in 2018
Thu, 09/06/2018 - 16:38 "Efil" Virus Removal/Antibacterial Spray to Go on Sale
Fri, 08/17/2018 - 14:44 Taiho Pharmaceutical Applies for Additional Indication of Gastric Cancer in Japan for its Anticancer agent LONSURF
Fri, 07/13/2018 - 16:23 Taiho Pharmaceutical Enters into Development of a Novel Immuno-Oncology Therapy with Arcus Biosciences
Sun, 12/17/2017 - 21:32 Taiho Pharmaceutical Signs a Co-promotion Agreement with Janssen Pharmaceutical K.K. for Guselkumab, a Human Anti-interleukin (IL)-23 Monoclonal Antibody, in Japan
Thu, 11/09/2017 - 19:17 Taiho Pharmaceutical Constructs Otsuka Group's Kitajima Plant Welfare and Office Building
Sun, 10/29/2017 - 23:25 Taiho to Donate a Total of JPY 55 Million to 15 Organizations Related to Cancer and Health, to Mark its 55th Anniversary
Thu, 10/19/2017 - 22:27 Health Canada Grants Priority Review Status to TAS-102 (brand name in Japan: "LONSURF ") for Refractory Metastatic Colorectal Cancer
Wed, 10/04/2017 - 20:33 Taiho Pharmaceutical Releases Pitas Sore Throat Troche in Japan on October 5
Tue, 10/03/2017 - 18:22 Taiho Pharmaceutical to Participate in Japan Healthcare Venture Summit 2017
Wed, 09/06/2017 - 19:50 Taiho Pharmaceutical releases Harncare Granules nationwide in Japan on Thursday, September 7an effective herbal remedy to improve urinary function by warming up the body from the inside.
Fri, 08/25/2017 - 01:47 Antitumor Agent Abraxane I.V. Infusion 100 mg Approved for Additional Dosage and Administration for Gastric Cancer
Thu, 05/18/2017 - 00:38 Taiho Pharmaceutical Receives Approval for the Additional Indications of Complicated Skin and Soft Tissue Infections for ZOSYN
more

InfoBox

HomePagewww.taiho.co.jp
Wikipediaen.wikipedia.org/wiki/Taiho_Pharmaceutical